Sfoglia per Autore
Targeting the subtypes of breast cancer: Rethinking investigational drugs
2012 G. Curigliano, M. Locatelli, L. Fumagalli, J. Brollo, E. Munzone, F. Nolé, C. Criscitiello, A. Goldhirsch
Cardiovascular toxicity induced by chemotherapy, targeted agents and radiotherapy: ESMO clinical practice guidelines
2012 G. Curigliano, D. Cardinale, T. Suter, G. Plataniotis, E. De azambuja, M.T. Sandri, C. Criscitiello, A. Goldhirsch, C. Cipolla, F. Roila
Best management of locally advanced inoperable breast cancer
2013 G. Curigliano, C. Criscitiello, A. Esposito, L. Fumagalli, L. Gelao, M. Locatelli, I. Minchella, A. Goldhirsch
Tumour dormancy and clinical implications in breast cancer
2013 L. Gelao, C. Criscitiello, L. Fumagalli, M. Locatelli, S. Manunta, A. Esposito, I. Minchella, A. Goldhirsch, G. Curigliano
Highlights from the 13th St Gallen International Breast Cancer Conference 2013 : access to innovation for patients with breast cancer: How to speed it up?
2013 G. Curigliano, C. Criscitiello, F. Andrè, M. Colleoni, A. Di Leo
Molecular pathways : human leukocyte antigen G(HLA-G)
2013 G. Curigliano, C. Criscitiello, L. Gelao, A. Goldhirsch
Developing an effective breast cancer vaccine : challenges to achieving sterile immunity versus resetting equilibrium
2013 G. Curigliano, C. Criscitiello, A. Esposito, L. Fumagalli, L. Gelao, M. Locatelli, I. Minchella, A. Goldhirsch
HER2 signaling pathway and trastuzumab cardiotoxicity
2013 C. Criscitiello, G. Curigliano
Immunotherapeutics for breast cancer
2013 C. Criscitiello, G. Curigliano
Adjuvant trastuzumab in elderly with HER-2 positive breast cancer : a systematic review of randomized controlled trials
2013 J. Brollo, G. Curigliano, D. Disalvatore, B.F. Marrone, C. Criscitiello, V. Bagnardi, M.C. Kneubil, L. Fumagalli, M. Locatelli, S. Manunta, A. Goldhirsch
Locoregional recurrence in patients with HER2 positive breast cancer
2013 J. Brollo, M.C. Kneubil, E. Botteri, N. Rotmensz, B.A. Duso, L. Fumagalli, M.A. Locatelli, C. Criscitiello, V. Lohsiriwat, A. Goldhirsch, M.G. Leonardi, R. Orecchia, G. Curigliano
Dinaciclib for the treatment of breast cancer
2014 C. Criscitiello, G. Viale, A. Esposito, G. Curigliano
Dendritic cell-based vaccines : clinical applications in breast cancer
2014 L. Gelao, C. Criscitiello, A. Esposito, M.D. Laurentiis, L. Fumagalli, M.A. Locatelli, I. Minchella, M. Santangelo, S.D. Placido, A. Goldhirsch, G. Curigliano
Barriers to the use of trastuzumab for HER2+ breast cancer and the potential impact of biosimilars : a physician survey in the united states and emerging markets
2014 P. Lammers, C. Criscitiello, G. Curigliano, I. Jacobs
Immune checkpoint blockade in cancer treatment : a double-edged sword cross-targeting the host as an "innocent bystander"
2014 L. Gelao, C. Criscitiello, A. Esposito, A. Goldhirsch, G. Curigliano
Monitoring tumor-derived cell-free DNA in patients with solid tumors : clinical perspectives and research opportunities
2014 A. Esposito, A. Bardelli, C. Criscitiello, N. Colombo, L. Gelao, L. Fumagalli, I. Minchella, M. Locatelli, A. Goldhirsch, G. Curigliano
Optimal adjuvant chemotherapy in breast cancer : selection of agents
2014 A. Esposito, C. Criscitiello, E. Omodeo Salè, G. Curigliano
Immune approaches to the treatment of breast cancer, around the corner?
2014 C. Criscitiello, A. Esposito, L. Gelao, L. Fumagalli, M. Locatelli, I. Minchella, L. Adamoli, A. Goldhirsch, G. Curigliano
Tumor-stroma crosstalk : targeting stroma in breast cancer
2014 C. C., E. A., G. Curigliano
Biopsy confirmation of metastatic sites in breast cancer patients : clinical impact and future perspectives
2014 C. Criscitiello, F. André, A.M. Thompson, M. De Laurentiis, A. Esposito, L. Gelao, L. Fumagalli, M. Locatelli, I. Minchella, F. Orsi, A. Goldhirsch, G. Curigliano
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile